Relation of C-reactive protein and one-year survival after acute myocardial infarction with versus without statin therapy

American Journal of Cardiology

Volumn 96, Issue 5, 2005, Pages 617-621

  Kinjo, Kunihiro ^a   Sato, Hiroshi ^a   Sakata, Yasuhiko ^a   Nakatani, Daisaku ^a   Mizuno, Hiroya ^a   Shimizu, Masahiko ^a   Nishino, Masami ^b   Ito, Hiroshi ^c   Tanouchi, Jun ^b   Nanto, Shinsuke ^d   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA ROSAI HOSPITAL   (Japan)

^c Sakurabashi Watanabe Hospital   (Japan)

^d KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; FEMALE; HUMAN; INFLAMMATION; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL TIME; TREATMENT OUTCOME;

C-REACTIVE PROTEIN; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL INFARCTION; SURVIVAL RATE;

EID: 23944438863     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.04.030     Document Type: Article

References (10)

1. K. Kinjo, H. Sato, Y. Ohnishi, E. Hishida, D. Nakatani, H. Mizuno, K. Imai, S. Nanto, M. Naka, Y. Matsumura, H. Takeda, M. Hori Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction Am J Cardiol 91 2003 931 935
2. K. Kinjo, H. Sato, H. Sato, Y. Ohnishi, E. Hishida, D. Nakatani, H. Mizuno, M. Fukunami, Y. Koretsune, H. Takeda, M. Hori Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention Am J Cardiol 92 2003 1150 1154
3. Y. Ohnishi, T. Tanaka, R. Yamada, K. Suematsu, M. Minami, K. Fujii, N. Hoki, K. Kodama, S. Nagata, T. Hayashi Identification of 187 single nucleotide polymorphisms (SNPs) among 41 candidate genes for ischemic heart disease in the Japanese population Hum Genet 106 2000 288 292
4. K. Ozaki, K. Inoue, H. Sato, A. Iida, Y. Ohnishi, A. Sekine, K. Odashiro, M. Nobuyoshi, M. Hori, Y. Nakamura, T. Tanaka Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro Nature 429 2004 72 75
5. P.M. Ridker, N. Rifai, M. Clearfield, J.R. Downs, S.E. Weis, J.S. Miles, A.M. Gotto Jr Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965
6. P.M. Ridker, N. Rifai, M.A. Pfeffer, F.M. Sacks, L.A. Moye, S. Goldman, G.C. Flaker, E. Braunwald Cholesterol and Recurrent Events (CARE) Investigators Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels Circulation 98 1998 839 844
7. D.H. Walter, S. Fichtlscherer, M.B. Britten, P. Rosin, W. Auch-Schwelk, V. Schachinger, A.M. Zeiher Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation J Am Coll Cardiol 38 2001 2006 2012
8. P. Libby, P.M. Ridker, A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
9. P.M. Ridker, C.P. Cannon, D. Morrow, N. Rifai, L.M. Rose, C.H. McCabe, M.A. Pfeffer, E. Braunwald Pravastatin or atorvastatin evaluation, infection therapy - Thrombolysis In Myocardial Infarction I. C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28
10. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, T. Crowe, W.J. Sasiela, J. Tsai, J. Orazem, R.D. Magorien, C. O'Shaughnessy, P. Ganz Reversal of atherosclerosis with aggressive lipid lowering I. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease N Engl J Med 352 2005 29 38